Label-free serum albumin nanoparticles for bioimaging and Trojan horse-like drug delivery
Source abstract
Abstract
Fluorescence-based detection is a susceptible and accurate tool utilized in diagnostics due to its lower interference and better sensitivity. Accordingly, protein-based nanomaterials have revolutionized the field of nano-theranostics for their biocompatibility and biodegradability characteristics. The typical applications are in diagnostics as biosensors and for controlled release drug delivery due to their biocompatibility, biodegradability, and non-immunogenic nature, along with possibilities for surface modifications. Nevertheless, the primary reason for cancer-related mortality worldwide is inefficient targeting, and hence there is an increasing demand for alternative advanced therapeutic strategies. The albumin nanoparticles loaded with active medicinal ingredients bind to several cell surface receptors and preferentially accumulate inside cancer cells, positioning them as a promising candidate for therapeutic drug delivery. In this study, we've synthesized autofluorescent albumin nanoparticles and demonstrated their potential in vitro pH sensing and imaging competence. The concurrent drug delivery potential of albumin nanoparticles was explored by increased reactive oxygen species production, altered mitochondrial membrane potential, and cell cycle analysis for apoptosis. Overall, the synthesized near-infrared fluorescent albumin nanoparticles with a long lifetime can be a potential theranostic agent for biomedical applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Protein Interaction Studies and Fluorescence Analysis · Nanoparticle-Based Drug Delivery · Advanced Biosensing Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Image-guided cancer surgery using near-infrared fluorescence10.1038/nrclinonc.2013.123 ↗
2. Microwave-assisted synthesis of quasi-pyramidal CuInS2 -ZnS nanocrystals for enhanced near-infrared targeted fluorescent imaging of subcutaneous melanoma
3. Tumor targeting strategies of smart fluorescent nanoparticles and their applications in cancer diagnosis and treatment10.1002/adma.201902409 ↗
4. Molecular fluorophores for deep-tissue bioimaging10.1021/acscentsci.0c00544 ↗
5. Protein nanoparticles: promising platforms for drug delivery applications10.1021/acsbiomaterials.8b01098 ↗
6. Bioinspired fluorescent dipeptide nanoparticles for targeted cancer cell imaging and real-time monitoring of drug release10.1038/nnano.2015.312 ↗
7. Protein-based nanomaterials and nanosystems for biomedical applications: a review10.1016/j.mattod.2020.11.015 ↗
8. In vivo and in vitro biocompatibility study of novel microemulsion hybridized with bovine serum albumin as nanocarrier for drug delivery10.1016/j.heliyon.2019.e01858 ↗
9. Albumin-based drug delivery: harnessing nature to cure disease10.1186/s40591-016-0048-8 ↗
10. Albumin and its application in drug delivery10.1517/17425247.2015.993313 ↗
11. Unraveling the mysteries of serum albumin-more than just a serum protein10.3389/fphys.2014.00299 ↗
12. Roles of albumin-binding proteins in cancer progression and biomimetic targeted drug delivery10.1002/cbic.201800201 ↗
13. Evidence for delivery of abraxane via a denatured-albumin transport system10.1021/acsami.1c03065 ↗
14. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel10.1158/1078-0432.CCR-05-1634 ↗
15. Cancer statistics, 2018
16. Targeting mTOR in acute lymphoblastic leukemia10.3390/cells8020190 ↗
17. SPARC expression correlates with tumor response to albumin-bound paclitaxel in head and neck cancer patients10.1593/tlo.09109 ↗
18. Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis10.1038/onc.2008.82 ↗
19. Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane10.1007/s00280-009-1099-1 ↗
20. Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles10.1016/j.ijpharm.2013.02.043 ↗
21. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
22. A self-assembled albumin-based nanoprobe for in vivo ratiometric photoacoustic pH imaging10.1002/adma.201503194 ↗
23. Strategies for preparing albumin-based nanoparticles for multifunctional bioimaging and drug delivery10.7150/thno.19365 ↗
24. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation10.1016/j.ijpharm.2007.06.028 ↗
25. Introducing Tween-curcumin niosomes: preparation, characterization and microenvironment study10.1039/C9SM02416F ↗
26. Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy10.1016/j.biomaterials.2009.07.008 ↗
27. Defective cell proliferation is an attribute of overexpressed Notch1 receptor and impaired autophagy in Fanconi Anemia10.1016/j.ygeno.2020.08.009 ↗
28. Self-assembled dual-drug loaded core-shell nanoparticles based on metal-free fully alternating polyester for cancer theranostics10.1016/j.msec.2019.03.041 ↗
29. In vivo study of poly (ethylene glycol)-poly (caprolactone)-modified folic acid nanocarriers as a pH responsive system for tumor-targeted co-delivery of tamoxifen and quercetin10.1016/j.jddst.2019.101283 ↗
30. Novel curcumin-loaded human serum albumin nanoparticles surface functionalized with folate: characterization and in vitro/vivo evaluation10.2147/DDDT.S112039 ↗
31. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices10.1016/0142-9612(96)82721-9 ↗
32. Reaction of proteins with glutaraldehyde10.1016/0003-9861(68)90554-7 ↗
33. Autofluorescence generation and elimination: a lesson from glutaraldehyde10.1039/c3cc40799c ↗
34. Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis
35. Novel green and red autofluorescent protein nanoparticles for cell imaging and in vivo biodegradation imaging and modeling10.1039/C6RA06783B ↗
36. Red emissive cross-linked chitosan and their nanoparticles for imaging the nucleoli of living cells10.1016/j.carbpol.2013.10.100 ↗
37. A general strategy to red-shift green fluorescent protein-based biosensors10.1038/s41589-020-0641-7 ↗
38. Unfolding and refolding of bovine serum albumin at acid pH: ultrasound and structural studies10.1529/biophysj.106.088963 ↗
39. Fluorescent probes and nanoparticles for intracellular sensing of pH values10.1088/2050-6120/2/4/042001 ↗
40. pH-responsive allochroic nanoparticles for the multicolor detection of breast cancer biomarkers10.1016/j.bios.2019.111780 ↗
41. High selectivity sensing of bovine serum albumin: the combination of glass nanopore and molecularly imprinted technology10.1016/j.bios.2021.113056 ↗
42. The role of surface properties on protein aggregation behavior in aqueous solution of different ph values10.1208/s12249-020-01663-7 ↗
43. Fluorescent indicators for intracellular pH10.1021/cr900249z ↗
44. Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy10.1016/S0305-7372(03)00106-3 ↗
45. Enhancement of chemotherapy by manipulation of tumour pH10.1038/sj.bjc.6690455 ↗
46. Human serum albumin nanoparticles as a novel delivery system for cabazitaxel
47. Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a review10.1016/j.jconrel.2012.10.015 ↗
48. Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis10.1182/blood-2002-07-2143 ↗